Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.
Shared 56 years ago
83 views
Shared 56 years ago
158 views
Shared 56 years ago
161K views
Shared 56 years ago
361 views
Shared 56 years ago
132 views
Shared 56 years ago
426K views
Shared 56 years ago
46K views
Shared 56 years ago
32K views
Shared 56 years ago
213K views
Shared 56 years ago
117K views
Shared 56 years ago
114K views
Shared 56 years ago
58 views
Shared 56 years ago
190 views
Shared 56 years ago
102 views
Shared 56 years ago
122 views
Shared 56 years ago
281 views
Shared 56 years ago
227 views
Shared 56 years ago
288 views
